Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.


In children with acute lymphoblastic leukaemia (ALL), measurements of minimal residual disease (MRD) during therapy provide crucial information about the response to treatment and the risk of relapse. Flow cytometry is a practical and widely applicable tool for monitoring MRD in patients with ALL. This approach is based on the identification of… (More)


  • Presentations referencing similar topics